Search results
Results from the WOW.Com Content Network
The population was made up of 124 Swiss men (43.2% of the population) and 14 (4.9%) non-Swiss men. There were 139 Swiss women (48.4%) and 10 (3.5%) non-Swiss women. [10] Of the population in the municipality 155 or about 59.4% were born in Albinen and lived there in 2000.
Tiếng Việt; 粵語; 中文; Edit links ... -6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1 4,7.0 5,28]triaconta-1(28),2,4,9,19,21,25(29) ... in rifampin or 1 ...
The rifamycin group includes the classic rifamycin drugs as well as the rifamycin derivatives rifampicin (or rifampin), rifabutin, rifapentine, rifalazil and rifaximin. Rifamycin, sold under the trade name Aemcolo, is approved in the United States for treatment of travelers' diarrhea in some circumstances. [1] [2] [3]
2,4,5-Trichlorophenoxyacetic acid (also known as 2,4,5-T), a synthetic auxin, is a chlorophenoxy acetic acid herbicide used to defoliate broad-leafed plants. It was developed in the late 1940s, synthesized by reaction of 2,4,5-Trichlorophenol and chloroacetic acid. It was widely used in the agricultural industry until being phased out, starting ...
Isoniazid/rifampicin, also known as isoniazid/rifampin, is a medication used to treat tuberculosis. [1] It is a fixed dose combination of isoniazid and rifampicin (rifampin). [1] It is used together with other antituberculosis medication. [1] It is taken by mouth. [1] It is on the World Health Organization's List of Essential Medicines. [2]
Rifapentine, sold under the brand name Priftin, is an antibiotic used in the treatment of tuberculosis. [2] In active tuberculosis it is used together with other antituberculosis medications. [2] In latent tuberculosis it is typically used with isoniazid. [2] It is taken by mouth. [2]
In Albinen ist noch der Dreiberg hinzugekommen, ansonsten hat das Wappen sich in der urtümlichen Form erhalten. In den Gassen Albinens ist das Kreuz über den Pforten der Spycher zu sehen. Eindrücklich präsentiert es sich aber in der ovalen Kirche der Gemeinde.
Rolapitant (INN, [2] trade name Varubi / v ə ˈ r uː b i / və-ROO-bee in the US and Varuby in the European Union) is a drug originally developed by Schering-Plough and licensed for clinical development by Tesaro, which acts as a selective NK 1 receptor antagonist (antagonist for the NK 1 receptor). [3]